Tsunenori Ouchida
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 23, 2025
JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2025
Constitutive STAT3 Signaling, in Comparison with STAT5, Enhances CAR T-cell Efficacy and Lowers Systemic Toxicity.
Journal: Cancer immunology research
Published: May 14, 2025
Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: June 05, 2024
Cx1Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: April 09, 2024
PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: April 09, 2024
Establishment of a Novel Anti-Mouse CCR1 Monoclonal Antibody C1Mab-6.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: March 21, 2024
Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: March 20, 2024
Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: January 18, 2024
PMab-301: An Anti-Giraffe Podoplanin Monoclonal Antibody for Immunohistochemistry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: December 27, 2023
Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: December 21, 2023
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C44Mab-94 against Gastric Carcinomas.
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C44Mab-94 against Gastric Carcinomas.
Journal: Antibodies (Basel, Switzerland)
Published: May 09, 2023
Last Updated: 09/26/2026